semaglutide approved by insurance coverage just changed for as many as 56 million Americans when it comes to the popular GLP-1 medications used to promote weight loss π Struggling with weight loss?
Description
This guide explores the clinical evidence, biomarker considerations, and how providers evaluate safety when considering GLP-1 therapy for patients with inflammatory bowel disease
While there was an explosion in the use of GLP-1 drugs in 2025, two pharmaceutical giants are preparing to debut their oral options in 2026
#SemaglutideDrugTest #DiabetesCare #WeightManagement #DrugTesting #HealthcareInsights

A big moment in obesity & metabolic medicine
